A team from the Research Institute of the McGill University Health Center (The Institute) have discovered a new type of extracellular vesicle released by migrating cancer cells, revealing a previously unknown way in which these cells shed their DNA as they move. Published today in the journal Nature Cell Biology, the findings show that these cells release tiny structures called motile vesicles (MoVes), which carry their genetic material, including cancer-associated mutations. The discovery raises important questions about the role these vesicles may play in cancer progression.
Key PointsAdvanced Micro Devices is expanding in the AI accelerator market, with OpenAI and Meta Platforms each signed to agreements covering up to 6 gigawatts of AMD GPUs.
Key PointsAdvanced Micro Devices is expanding in the AI accelerator market, with OpenAI and Meta Platforms each signed to agreements covering up to 6 gigawatts of AMD GPUs.
Key PointsAdvanced Micro Devices is expanding in the AI accelerator market, with OpenAI and Meta Platforms each signed to agreements covering up to 6 gigawatts of AMD GPUs.
The Alpha Architect US Quantitative Value ETF is seeing unusually high volume in afternoon trading Wednesday, with over 386,000 shares traded versus three month average volume of about 33,000. Shares of QVAL were up about 0.1% on the day.
Components of that ETF with the highes
The Alpha Architect US Quantitative Value ETF is seeing unusually high volume in afternoon trading Wednesday, with over 386,000 shares traded versus three month average volume of about 33,000. Shares of QVAL were up about 0.1% on the day.
Components of that ETF with the highes
The Alpha Architect US Quantitative Value ETF is seeing unusually high volume in afternoon trading Wednesday, with over 386,000 shares traded versus three month average volume of about 33,000. Shares of QVAL were up about 0.1% on the day.
Components of that ETF with the highes
In trading on Wednesday, the ARK Genomic Revolution ETF is outperforming other ETFs, up about 6.1% on the day. Components of that ETF showing particular strength include shares of Pacific Biosciences of California, up about 22.5% and shares of Prime Medicine, up about 19.3% on
In trading on Wednesday, the ARK Genomic Revolution ETF is outperforming other ETFs, up about 6.1% on the day. Components of that ETF showing particular strength include shares of Pacific Biosciences of California, up about 22.5% and shares of Prime Medicine, up about 19.3% on
In trading on Wednesday, the ARK Genomic Revolution ETF is outperforming other ETFs, up about 6.1% on the day. Components of that ETF showing particular strength include shares of Pacific Biosciences of California, up about 22.5% and shares of Prime Medicine, up about 19.3% on
Britain’s efforts to protect millions of its households from rising energy costs this winter will have barely any effect on the overall level of inflation, the country’s fiscal watchdog said.
Meta says it may push the implementation of its new business terms past November 20th as it faces backlash from publishers over concerns about AI training. In a post on X, Meta communications head Andy Stone said the company does "not plan to make policy changes without a full consultation with industry groups and leaders." […]
Exit polls show Prime Minister Benjamin Netanyahu's alliance and Gadi Eisenkot's opposition bloc both well off the numbers needed to form a governing majority.
Exit polls show Prime Minister Benjamin Netanyahu's alliance and Gadi Eisenkot's opposition bloc both well off the numbers needed to form a governing majority.
Exit polls show Prime Minister Benjamin Netanyahu's alliance and Gadi Eisenkot's opposition bloc both well off the numbers needed to form a governing majority.
With celebrity star power, clean-label condiments, and a massive Sam’s Club expansion, the organic pantry startup is proving that big-box retail is the ultimate incubator for high-growth CPG brands.
HHS is pausing legal action against compounding pharmacies that make certain peptides, effectively allowing them to offer the unapproved drugs immediately.